Pfizer seeking emergency use of COVID-19 vaccine
Pfizer Inc. announced Friday that they seeking approval of U.S. regulators to allow the use of it’s COVID-19 vaccine.
Before any vaccine is approved for the public the U.S. Food and Drug Administration must conduct a full review of the vaccine trials, a process that normally takes about a decade.
The pandemic has caused the federal government to use various methods to speed up the process for COVID-19 vaccines.
On Wednesday, Pfizer released it’s preliminary data showing the vaccine is 95% effective.
The company said the data and good safety measures should help the vaccine qualify for emergency use authorization.
Watch the video for the full story.
Online sales, driven by social media, boost small businesses during pandemic
Mission EDC launches 'Small Business Market Days' to boost local economy
Tamaulipas reactivates COVID-19 checkpoints for Thanksgiving holiday weekend
McAllen Holiday Parade announces celebrity hosts
Donna police officer says he was shot while driving to work